Pharmacokinetics of Once-Daily Darunavir-Ritonavir and Atazanavir-Ritonavir over 72 Hours following Drug Cessation

The object of this study was to investigate the pharmacokinetics of darunavir-ritonavir and atazanavir-ritonavir once-daily dosing over 72 h (h) following drug intake cessation. Volunteers received darunavir-ritonavir at 800 and 100 mg, respectively, once daily for 10 days, followed by a 7-day washo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Boffito, Marta, Jackson, Akil, Amara, Alieu, Back, David, Khoo, Saye, Higgs, Chris, Seymour, Natalia, Gazzard, Brian, Moyle, Graeme
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2011
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165362/
https://ncbi.nlm.nih.gov/pubmed/21709075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01747-10
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak